ArticleFrontiers in immunology2023

Corrigendum: The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.

Guanyun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.